Carbapenem-resistant Acinetobacter baumannii infections among diabetic and non-diabetic patients and possible effective combination treatments

Abstract Background Carbapenems are one of the most noteworthy choices for treating multidrug-resistant Acinetobacter baumannii (A. baumannii). Currently, carbapenem-resistant A. baumannii (CRAB) represents a healthcare problem worldwide, particularly among diabetic patients who are more susceptible...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Aya M. Ghareeb, Marwa M. Raafat, Naglaa S. Bazan, Reham Samir
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	SpringerOpen 2024-07-01
Rangatū:	Future Journal of Pharmaceutical Sciences
Ngā marau:	A. baumannii Antibiotics combinations Carbapenem resistance genes Diabetes Multidrug resistance
Urunga tuihono:	https://doi.org/10.1186/s43094-024-00661-x
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!